<?xml version="1.0" encoding="UTF-8"?>
<p>Information about IFN-I induction and signaling as well as IFN-I evasion by viral proteins after SLEV infection in human cells is currently very limited. Former studies have shown a variable effect of human IFN in primary human fetal glial cell cultures [
 <xref rid="B267" ref-type="bibr">267</xref>]. Similar to DENV, ZIKV, and WNV, the protective role of IFN-I against SLEV has been demonstrated in mice since IFN signaling-deficient mice are more susceptible to infection by SLEV than in immunocompetent mice [
 <xref rid="B268" ref-type="bibr">268</xref>]. Specifically, the protective effects of IFN-
 <italic>Î±</italic> have been shown in mice by reducing mortality from SLEV delivered by the aerosol and subcutaneous routes [
 <xref rid="B269" ref-type="bibr">269</xref>].
</p>
